Berger JG - Search Results

1

Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity.

Clader JW, Berger JG, Burrier RE, Davis HR, Domalski M, Dugar S, Kogan TP, Salisbury B, Vaccaro W. Clader JW, et al. Among authors: berger jg. J Med Chem. 1995 May 12;38(10):1600-7. doi: 10.1021/jm00010a004. J Med Chem. 1995. PMID: 7752185

2

Inhibitors of acyl CoA:cholesterol acyltransferase.

Vaccaro W, Amore C, Berger J, Burrier R, Clader J, Davis H, Domalski M, Fevig T, Salisbury B, Sher R. Vaccaro W, et al. J Med Chem. 1996 Apr 12;39(8):1704-19. doi: 10.1021/jm950833d. J Med Chem. 1996. PMID: 8648610

3

Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.

Berger JG, Chang WK, Clader JW, Hou D, Chipkin RE, McPhail AT. Berger JG, et al. J Med Chem. 1989 Aug;32(8):1913-21. doi: 10.1021/jm00128a038. J Med Chem. 1989. PMID: 2666667

4

SCH 57790: a novel M2 receptor selective antagonist.

Lachowicz JE, Lowe D, Duffy RA, Ruperto V, Taylor LA, Guzik H, Brown J, Berger JG, Tice M, McQuade R, Kozlowski J, Clader J, Strader CD, Murgolo N. Lachowicz JE, et al. Among authors: berger jg. Life Sci. 1999;64(6-7):535-9. doi: 10.1016/s0024-3205(98)00598-0. Life Sci. 1999. PMID: 10069520

5

Carboxyalkyl dipeptides with atrial natriuretic factor potentiating and antihypertensive activity.

Haslanger MF, Sybertz EJ, Neustadt BR, Smith EM, Nechuta TL, Berger J. Haslanger MF, et al. J Med Chem. 1989 Apr;32(4):737-9. doi: 10.1021/jm00124a002. J Med Chem. 1989. PMID: 2522989 No abstract available.

6

Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.

Chipkin RE, Berger JG, Billard W, Iorio LC, Chapman R, Barnett A. Chipkin RE, et al. Among authors: berger jg. J Pharmacol Exp Ther. 1988 Jun;245(3):829-38. J Pharmacol Exp Ther. 1988. PMID: 3164388

7

Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A. Chipkin RE, et al. Among authors: berger jg. J Pharmacol Exp Ther. 1988 Dec;247(3):1093-102. J Pharmacol Exp Ther. 1988. PMID: 2905002

8

Application of an almost traceless linker in the synthesis of 2-alkylthiobenzimidazole combinatorial libraries.

Slade RM, Phillips MA, Berger JG. Slade RM, et al. Among authors: berger jg. Mol Divers. 1998;4(4):215-9. doi: 10.1023/a:1009696618386. Mol Divers. 1998. PMID: 10849898

9

Affinity chromatography of the D1 dopamine receptor from rat corpus striatum.

Gingrich JA, Amlaiky N, Senogles SE, Chang WK, McQuade RD, Berger JG, Caron MG. Gingrich JA, et al. Among authors: berger jg. Biochemistry. 1988 May 31;27(11):3907-12. doi: 10.1021/bi00411a003. Biochemistry. 1988. PMID: 3415962

10

Biochemical properties of D1 and D2 dopamine receptors.

Senogles SE, Amlaiky N, Berger JG, Caron MG. Senogles SE, et al. Among authors: berger jg. Adv Exp Med Biol. 1988;235:33-41. doi: 10.1007/978-1-4899-2723-1_3. Adv Exp Med Biol. 1988. PMID: 2976252 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page